Texas Administrative Code › Title 25 - HEALTH SERVICES › Part 1 - DEPARTMENT OF STATE HEALTH SERVICES › Chapter 229 - FOOD AND DRUG › Subchapter J - MINIMUM STANDARDS FOR NARCOTIC TREATMENT PROGRAMS › Section 229.150 - Central Registry

Current through Reg. 49, No. 28; July 12, 2024
(a) The permit
				  holder shall participate in the central registry for the purpose of sharing
				  patient identifying information as requested by the department to prevent
				  multiple enrollment of patients in narcotic treatment programs
				  (NTPs).
(b) A narcotic drug shall
				  not be provided to a patient who is known to be currently enrolled in another
				  NTP except when the patient is a temporary transfer patient.
(c) The patient shall always report to the
				  same NTP unless prior approval is requested by the parent NTP's program
				  physician or program director for the patient to receive treatment as a
				  temporary transfer patient at another NTP. In any event, a patient may not be
				  authorized more than two weeks away from their home clinic without prior
				  approval from the State Methadone Authority (SMA).
(d) A central registry shall be established
				  by the department which shall maintain a record of the patient's identification
				  and the NTP to which each patient is enrolled. Information shall be maintained
				  in accordance with confidentiality requirements in the Code of Federal
				  Regulations, Title 42, Part 2, and Title 42, §8.12(g).
(e) Each NTP shall report to the central
				  registry specific information.
(1) The
				  following changes in patient status: new patient, readmitted to the same
				  clinic, admitted from another NTP as a permanent transfer patient, transferred
				  to another narcotic maintenance or detoxification program, deceased patient, or
				  discharged (terminated) from maintenance or detoxification treatment shall be
				  identified and reported to the central registry located at the department by
				  telephone, electronic mail, or facsimile on the day the action occurs and
				  written documentation must be submitted within a 24-hour period (or the next
				  state working day immediately following weekends or holidays).
(2) Each NTP's verbal and written report to
				  the central registry shall identify and provide the following information for
				  each patient:
(A) name, address, and
				  telephone number of the NTP, and approved narcotic drug permit
				  number;
(B) date action was taken
				  (MO-DA-YR);
(C) action taken
				  identified as:
(i) new patient, readmitted
				  patient (NP);
(ii) terminated
				  patient (TP);
(iii) permanent
				  transfer-in patient (TIP);
(iv)
				  permanent transfer-out patient (TOP); or
(v) deceased patient (DP); and
(D) patient identification as
				  follows:
(i) Upon admission, the patient must
				  be identified with a current Texas state driver's license, United States
				  passport, military identification card, or Texas state-issued identification
				  card containing a photograph of the patient or other identification approved by
				  the SMA. If a patient is not able or willing to furnish the required documents,
				  the program shall contact the SMA within 72 hours to access the Central
				  Registry to check for possible duplicate enrollment and to discuss acceptable,
				  alternate forms of identification. Photocopies of each of these documents must
				  be maintained in the patient's record. The program shall document in the
				  patient's file attempts to induce the patient to obtain state
				  identification.
(ii) An
				  identification number shall be constructed using the following code numbers for
				  the patient:
(I) color of eyes: Brown (1),
				  Blue (2), Green (3), Hazel (4), Gray (5), and Other (6);
(II) date of birth stated in number digits
				  with two digits for the month, day, and year (example: January 9,
				  1953--010953);
(III) gender: male
				  (1) and female (2); and
(IV) race:
				  White (1), Black (2), Hispanic (3), Asian (4), American Indian (5), and Other
				  (6).
(iii) An example of
				  a patient identification number in accordance with clause (ii) of this
				  subparagraph for a patient with blue eyes, date of birth--January 9, 1953,
				  male, and white is 201095311. Patients with the same identification code will
				  be assigned an alphabetical extension by the SMA (for example 201095311A,
				  201095311B, etc.).